Active Ingredient History

NOW
  • Now
Selepressin (INN), also known as [Phe(2),Ile(3), Hgn(4),Orn(iPr)(8)]vasopressin) is a potent, highly selective, short-acting peptide full agonist of the vasopressin 1A receptor and analog of vasopressin which was under development by Ferring Pharmaceuticals for the treatment of vasodilatory hypotension in septic shock.   Wikipedia

  • SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](N)CSSC[C@H](NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCC(=O)N)NC1=O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CCCNC(C)C)C(=O)NCC(=O)N
  • InChIKey: JCVQBJTWWDYUFQ-MRUTUVJXSA-N
  • Mol. Mass: 1048.3
  • ALogP: Missing data
  • ChEMBL Molecule:
More Chemistry
2-phe-3-ile-4-hgn-8-orn(ipr)-vasopressin | fe202158 | fe 202158 | fe-202158 | (phe2,ile3,hgn4,orn(ipr)8)vasopressin | selepressin | vasopressin, phe(2)-ile(3)-hgn(4)-orn(ipr)(8)- | vasopressin, phenylalanyl(2)-isoleucyl(3)-hgn(4)-ornithyl(isopropyl)(8)-

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue